| Patents for A61P 3 - Drugs for disorders of the metabolism (129,789) |
|---|
| 02/21/2002 | WO2002013798A2 Treatment of the insulin resistance syndrome with selective cgmp pde5 inhibitors |
| 02/21/2002 | WO2002013797A2 Therapeutic combination of a cetp inhibitor and atorvastatin |
| 02/21/2002 | WO2002013782A1 Oral delivery of peptide |
| 02/21/2002 | WO2002013759A2 Method of treating the syndrome of type 2 diabetes in humans |
| 02/21/2002 | WO2002013758A2 System for regulating in vivo the expression of a transgene by conditional inhibition |
| 02/21/2002 | WO2001090063A3 Prodrug of an ice inhibitor |
| 02/21/2002 | WO2001085256A3 Critical illness neuropathy |
| 02/21/2002 | WO2001082873A3 A medicinal aerosol formulation |
| 02/21/2002 | WO2001081328A3 Thiazolidinedione analogues and their use for the treatment of diabetes |
| 02/21/2002 | WO2001079443A3 Albumin fusion proteins |
| 02/21/2002 | WO2001078533A3 Nutritional modules |
| 02/21/2002 | WO2001072977A3 Isolated human drug-metabolizing proteins, nucleic acid molecules encoding human drug-metabolizing proteins, and uses thereof |
| 02/21/2002 | WO2001072960A3 Il-8 receptor antagonists |
| 02/21/2002 | WO2001070807A3 G-protein associated molecules |
| 02/21/2002 | WO2001068609B1 1,2,3,4-tetrahydroisoquinoline derivatives |
| 02/21/2002 | WO2001066747A8 Proteins named fctrx and nucleic acids encoding same |
| 02/21/2002 | WO2001054711A3 Use of neurotoxins for treating diabetes |
| 02/21/2002 | WO2001052817A3 Cochleate formulations and their use for delivering biologically relevant molecules |
| 02/21/2002 | WO2001047510A3 Methods and compositions related to modulators of annexin and cartilage homeostasis |
| 02/21/2002 | WO2001046397A3 Human kinases |
| 02/21/2002 | WO2001043775A3 Hydroxide-releasing agents as skin permeation enhancers |
| 02/21/2002 | WO2001031005A3 Drosophila g protein coupled receptors, nucleic acids, and methods related to the same |
| 02/21/2002 | WO2001019158A3 An anti-oxidant preparation based on plant extracts for the treatment of circulation and adiposity problems |
| 02/21/2002 | WO2000066148A9 Novel proteins |
| 02/21/2002 | WO2000054729A8 Heterocyclic aromatic compounds useful as growth hormone secretagogues |
| 02/21/2002 | US20020022729 Pyridylfuran and pyridylthiophene compounds |
| 02/21/2002 | US20020022648 Novel 2H-tetrazole-amide compounds with therapeutic activity as metabotropic glutamate receptor agonists |
| 02/21/2002 | US20020022646 Method for systhesizing leflunomide |
| 02/21/2002 | US20020022645 Administering benzofuran derivative for therapy of disease state that is capable of being modulated by inhibition of phosphodiesterase IV or Tumour Necrosis Factor |
| 02/21/2002 | US20020022642 As nitric oxide synthase (NOS) inhibitors, used in therapy and prophylaxis of central nervous system disorders, inflammatory disorders, septic shock and other disorders |
| 02/21/2002 | US20020022640 Methods for treatment of cognitive and menopausal disorders with D-threo methylphenidate |
| 02/21/2002 | US20020022637 Tetrahydroisoquinoline analogs useful as growth hormone secretagogues |
| 02/21/2002 | US20020022628 Useful as metalloproteinase inhibitor; piperazino-sulfonamide or piperidino-sulfonamide compound |
| 02/21/2002 | US20020022622 Administering effective amount of oxalzole, thiazole or imidazole derivatives to cure diseases associated with protein aging |
| 02/21/2002 | US20020022620 Reverse-turn mimetics and methods relating thereto |
| 02/21/2002 | US20020022619 Administering to the mammal suffering from anxiety, depression and other disorders related to excessive corticotropin releasing factor an effective amount of tricyclic pyridine or pyrimidine derivatives |
| 02/21/2002 | US20020022617 Methods for increasing nitric oxide synthase activity |
| 02/21/2002 | US20020022605 Cyclamine sulfonamides as beta-3 adrenergic receptor agonists |
| 02/21/2002 | US20020022236 Accurately measuring albumin in urine sample; obtain urine, detect presence of adjusted and wildtype albumin in sample |
| 02/21/2002 | US20020022036 Administering high molecular weight urine isolate; anticancer, Aids therapy |
| 02/21/2002 | US20020020784 Flexible kite |
| 02/21/2002 | DE10039998A1 Neue substituierte Diareno-azepin-Derivate als Integrin Liganden New substituted Diareno-azepine derivatives as integrin ligands |
| 02/21/2002 | CA2420032A1 Oral delivery of peptide |
| 02/21/2002 | CA2419790A1 System for regulating in vivo the expression of a transgene by conditional inhibition |
| 02/21/2002 | CA2419406A1 Pharmaceutical combinations of torcetrapib and atorvastatin or hydroxy derivatives for the treatment of atherosclerosis, angina and low hdl levels |
| 02/21/2002 | CA2419158A1 Method for the prevention and treatment of retinopathy |
| 02/21/2002 | CA2419073A1 Novel alicyclic imidazoles as h3 agents |
| 02/21/2002 | CA2419033A1 Treatment of the insulin resistance syndrome with selective cgmp pde5 inhibitors |
| 02/21/2002 | CA2418716A1 Integrin binding motif containing peptides and methods of treating skeletal diseases |
| 02/21/2002 | CA2418389A1 Pyridine derivatives as inhibitors of p38 |
| 02/21/2002 | CA2418273A1 Urea compounds and methods of uses |
| 02/21/2002 | CA2418266A1 Novel mitogen activated kinase |
| 02/21/2002 | CA2417846A1 2-aminopyridine compounds and medical use thereof |
| 02/21/2002 | CA2416898A1 Method and composition for altering a b cell mediated pathology |
| 02/21/2002 | CA2416794A1 Method and composition for altering a t cell mediated pathology |
| 02/21/2002 | CA2387548A1 Bioavailable composition of natural and synthetic hca |
| 02/21/2002 | CA2386985A1 Compositions and methods for inhibiting islet dysfunction and autoimmune disorders |
| 02/20/2002 | EP1180520A1 Heterocyclic carboxylic acid derivatives |
| 02/20/2002 | EP1180519A1 Hydrochloride of fused-heterocycle compound |
| 02/20/2002 | EP1180518A1 5-pyridyl-1,3-azole compounds, process for producing the same and use thereof |
| 02/20/2002 | EP1180514A1 Nitrogen-containing heterocyclic compounds and benamide compounds and drugs containing the same |
| 02/20/2002 | EP1180144A2 Cytoskeleton-associated proteins |
| 02/20/2002 | EP1180143A2 Methods of inducing regulated pancreatic hormone production in non-pancreatic islet tissues |
| 02/20/2002 | EP1180140A1 Variants of traf2 which act as an inhibitor of tnf-alpha signaling pathway |
| 02/20/2002 | EP1180121A1 Long lasting insulinotropic peptides |
| 02/20/2002 | EP1180105A2 Substituted aza-oxindole derivatives |
| 02/20/2002 | EP1180102A1 Mutual prodrugs of amlodipine and atorvastatin |
| 02/20/2002 | EP1180097A1 Mutual salt of amlodipine and atorvastatin |
| 02/20/2002 | EP1180035A1 NON-CALCEMIC, ANTIPROLIFERATIVE, TRANSCRIPTIONALLY ACTIVE SULFUR-CONTAINING ANALOGS OF 1$g(a), 25-DIHYDROXY VITAMIN D 3? |
| 02/20/2002 | EP1180029A1 Bicyclic acyl guanidine sodium/proton exchange inhibitors and method |
| 02/20/2002 | EP1041896B1 Fat blend |
| 02/20/2002 | CN1336922A Hypolipidemic and antioxidant morpholine derivatives |
| 02/20/2002 | CN1336921A Fused ring heteroaryl and heterocyclic compounds which inhibit leukocyte adhesion mediated by VLA-4 |
| 02/20/2002 | CN1336430A Antilipemic health vinegar |
| 02/20/2002 | CN1336380A Anticancer polypeptide |
| 02/20/2002 | CN1336366A Intermediate of N-benzyl dioxothiazolidinyl benzoyl amide derivatives, and its prepn. method |
| 02/20/2002 | CN1336224A Diabetes treating traditional Chinese medicine |
| 02/20/2002 | CN1336212A Diabetes treating medicine |
| 02/20/2002 | CN1336206A Health tea for preventing and treating hypertension, byperlipemia and high blood viscosity disease |
| 02/20/2002 | CN1336195A Prepn. of calcium replenishing liquid with composite functions |
| 02/20/2002 | CN1336194A Natural and high-protein health bolus and its prepn. |
| 02/20/2002 | CN1336193A Antilipenic functional water containing natural medicine component and its compounding process |
| 02/20/2002 | CN1336185A Hypolycemic functional water containing natural medicine component and its compounding process |
| 02/20/2002 | CN1336179A Diabetes granule |
| 02/20/2002 | CN1079390C Propynyl or dienyl diaromatic compounds |
| 02/20/2002 | CN1079264C Hypoglyemic liquid medicine |
| 02/19/2002 | USRE37556 Superoxide radical inhibitor |
| 02/19/2002 | US6348609 Method for obtaining an oil that is rich in hydroxyoctadecadienoic fatty acids (HODE) or the esters thereof from a mixture containing linoleic acid or the esters thereof |
| 02/19/2002 | US6348472 NPY antagonists: spiroisoquinolinone derivatives |
| 02/19/2002 | US6348466 CRF receptor antagonists and methods relating thereto |
| 02/19/2002 | US6348463 Phenylalanine derivatives |
| 02/19/2002 | US6348335 Metabolism active materials, heating and cooling yeasts then isolation |
| 02/19/2002 | US6348090 Film coatings and film coating compositions based on dextrin |
| 02/19/2002 | CA2203274C Apolipoprotein-b synthesis inhibitors |
| 02/19/2002 | CA2103889C Process for the phosphorylation of insulin and product produced thereby |
| 02/19/2002 | CA2023246C Mutants of human interleukin-3 |
| 02/19/2002 | CA2004461C Method for the stimulation of bone marrow cells |
| 02/14/2002 | WO2002012467A2 Drug metabolizing enzymes |
| 02/14/2002 | WO2002012346A2 A new slit-like protein obtained from a cdna library from hs-5 stromal cell line |
| 02/14/2002 | WO2002012340A2 Transporters and ion channels |